Journal of Drug Targeting

Papers
(The median citation count of Journal of Drug Targeting is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Methotrexate-Loaded solid lipid nanoparticles enhance the viability of cutaneous flaps: potential for surgical wound healing48
Synergistic cancer treatment using porphyrin-based metal-organic Frameworks for photodynamic and photothermal therapy47
Artificial intelligence-based molecular property prediction of photosensitising effects of drugs43
Nano-based drug delivery systems in hepatocellular carcinoma42
Edoxaban enfolded beta-1,4-poly- d -glucosamine nanoparticles for targeting eponym Stuart–Prower factor for treatment of venous thrombosis40
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches39
Self-nanoemulsifying drug delivery system (SNEDDS) as nano-carrier framework for permeability modulating approaches of BCS class III drug39
RETRACTED ARTICLE: Melanin-based biomimic photothermal nanoparticles for therapeutic application in diabetic nephropathy34
Statement of Retraction: Melanin-based biomimic photothermal nanoparticles for therapeutic application in diabetic nephropathy31
MicroRNA-206 inhibition and activation of the AMPK/Nampt signalling pathway enhance sevoflurane post-conditioning-induced amelioration of myocardial ischaemia/reperfusion injury29
Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer28
Progress in tumour-targeted drug delivery based on cell-penetrating peptides26
ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance25
Novel pH-responsive alginate-stabilized curcumin–selenium–ZIF-8 nanocomposites for synergistic breast cancer therapy25
Advances in autophagy as a target in the treatment of tumours24
Cancer stem cell biomarkers and related signalling pathways24
State-of-the-art drug delivery system to target the lymphatics23
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma21
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis21
Research progress of exosomes as drug carriers in cancer and inflammation21
Advancement in transporter-oriented nanoplatforms for cancer therapy20
In vitro studies support clinical trials showing platelet-rich fibrin-mediated local delivery of antibiotics improves outcomes in impacted mandibular third molar surgery20
Delivery of MERS antigen encapsulated in α-GalCer-bearing liposomes elicits stronger antigen-specific immune responses20
Cell-based immunotherapy in oesophageal cancer19
Role of exosomes in tumour growth, chemoresistance and immunity: state-of-the-art19
Effects and mechanisms of natural plant active compounds for the treatment of osteoclast-mediated bone destructive diseases18
Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model18
Her-2-directed systemic delivery of fatty acid synthase (FASN) siRNA with novel liposomal carrier systems in the breast cancer mouse model18
Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection18
Targeting E7 antigen to the endoplasmic reticulum degradation pathway promotes a potent therapeutic antitumor effect17
Nanoreactor activated in situ for starvation-chemodynamic therapy of breast cancer17
Valeric acid reduction by chitosan oligosaccharide induces autophagy in a Parkinson’s disease mouse model17
Impact of tumoral structure and bacterial species on growth and biodistribution of live bacterial therapeutics in xenografted tumours17
Multifunctional metal complex-based gene delivery for tumour immune checkpoint blockade combination therapy16
Development and characterization of a novel neutralizing scFv vectored immunoprophylaxis against botulinum toxin type A15
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma15
Factors of faecal microbiota transplantation applied to cancer management15
ceRNA networks in gynecological cancers progression and resistance15
Metformin combats obesity by targeting FTO in an m6A-YTHDF2-dependent manner15
Indocyanine green-loaded N-doped carbon quantum dot nanoparticles for effective photodynamic therapy and cell imaging of melanoma cancer: in vitro , ex vi14
Desmethoxycurcumin aids IFNα’s anti-HBV activity by antagonising CRYAB reduction and stabilising IFNAR1 protein14
Ferroptosis in renal fibrosis: a mini-review14
Progress in research and development of temozolomide brain-targeted preparations: a review14
Hybrid nano-stimulator for specific amplification of oxidative stress and precise tumour treatment13
Evaluation of anti-diabetic effects of glimepiride/metformin cocrystal13
Evaluation of mRNA lipoplexes prepared using modified ethanol injection method as a tumour vaccine13
Regulation of IFP in solid tumours through acoustic pressure to enhance infiltration of nanoparticles of various sizes13
The applications of targeted delivery for gene therapies in hearing loss13
Enhanced antitumor activity induced by a DNA vaccine encoding E7 antigen fused to an ERAD-targeting sequence12
Methods for fabricating oxygen releasing biomaterials12
Lymphatic targeting for therapeutic application using nanoparticulate systems12
Harnessing machine learning potential for personalised drug design and overcoming drug resistance12
Advancing biofilm management through nanoformulation strategies: a review of dosage forms and administration routes12
Epigenetic modulation: Research progress on histone acetylation levels in major depressive disorders12
Recent advances in hepatocellular carcinoma therapeutic strategies and imaging-guided treatment12
Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer11
A critical review on the role of nanotheranostics mediated approaches for targeting β amyloid in Alzheimer’s11
Evaluating the reliability of tumour spheroid-on-chip models for replicating intratumoural drug delivery: considering the role of microfluidic parameters11
Green synthesis of magnesium oxide nanoparticles using the extract of Falcaria vulgaris to enhance the healing of burn wounds11
Targeted therapy of tumour microenvironment by gold nanoparticles as a new therapeutic approach11
Hydrogel doped with sinomenine-CeO 2 nanoparticles for sustained intra-articular therapy in knee osteoarthritis11
Nanoliposomes as drug delivery systems: safety concerns10
Ultrasound image-guided gene delivery using three-dimensional diagnostic ultrasound and lipid-based microbubbles10
Targetting ferroptosis for blood cell-related diseases10
Design and Formulation of Fast-Dissolving Microneedles for the Rapid Transdermal Delivery of Lorazepam10
Trimethyl chitosan–cysteine-based nanoparticles as an effective delivery system for portulacerebroside A in the management of hepatocellular carcinoma cells in vitro and10
Exosome-mediated transfer of circHIPK3 promotes trastuzumab chemoresistance in breast cancer10
Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target9
Selection of LRP1 ligand phage-displayed single domain antibody that transmigrates BBB9
Nanoparticle-Based gene therapy strategies in retinal delivery9
Comprehensive developmental investigation on simvastatin enriched bioactive film forming spray using the quality by design paradigm: a prospective strategy for improved wound healing9
A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches9
Targeting cellular energy metabolism- mediated ferroptosis by small molecule compounds for colorectal cancer therapy9
Development of linagliptin-loaded liposomes using aspartic acid conjugate for bone-targeted delivery to combat osteoporosis9
An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles9
Artificial intelligence for skin permeability prediction: deep learning9
The combined treatment of gold nanoparticles associated with photobiomodulation accelerate the healing of dermonecrotic lesion9
Roles and therapeutic targeting of dendritic cells in liver fibrosis9
Igniting tumour microenvironment in triple-negative breast cancer using a mannose/hyaluronic acid dual-coated Ganoderma polysaccharide-superparamagnetic iron oxide nanocomplex for combinational therap8
Correction8
Role of liposomes in chemoimmunotherapy of breast cancer8
Emerging advances in nano-biomaterial assisted amyloid beta chimeric antigen receptor macrophages (CAR-M) therapy: reducing plaque burden in Alzheimer’s disease8
Folate-conjugated carbon nanotubes as a promising therapeutic approach for targeted cancer therapy8
Pharmaceutical cocrystals: a rising star in drug delivery applications8
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer8
Novel strategies for the fight of Alzheimer’s disease targeting amyloid-β protein7
Epidermal growth factor receptors unveiled: a comprehensive survey on mutations, clinical insights of global inhibitors, and emergence of heterocyclic derivatives as EGFR inhibitors7
Geriatric drug delivery ― barriers, current technologies and the road ahead7
Chitosan tamarind-based nanoparticles as a promising approach for topical application of curcumin intended for burn healing: in vitro and in vivo 7
Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumour-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer7
A bispecific decoy receptor VEGFR-EGFR/Fc binding EGF-like ligands and VEGF shows potent antitumor efficacy7
Anti-GPC3 antibody and cell-penetrating peptide CPP44 dual-ligand modified liposomes for targeted delivery of arsenic trioxide in the treatment of hepatocellular carcinoma7
In vivoandin vitroimpact of atorvastatin against myocardial ischaemia-reperfusion injury by upregulation of silent information regulator l and attenuation of endoplasmic reticulum stress7
Nanotransethosomal dual-drug loaded gel of methotrexate and mangiferin as a potent synergistic intervention for rheumatoid arthritis via transdermal delivery7
Exploring nalbuphine loaded chitosan nanoparticles for effective pain management through intranasal administration: a comparative study7
Targeting the lung tumour stroma: harnessing nanoparticles for effective therapeutic interventions7
Liver-targeted delivery based on prodrug: passive and active approaches7
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells6
Colon-targeted delivery of niclosamide from solid dispersion employing a pH-dependent polymer via hotmelt extrusion for the treatment of ulcerative colitis in mice6
Correction6
Recent advances in cancer cell bionic nanoparticles for tumour therapy6
Aptamer as a targeted approach towards treatment of breast cancer6
Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy6
Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway6
A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates6
Studies of a novel bone-targeted nano drug delivery system with a HAP core-PSI coating structure for tanshinol injection6
ZIF-8 nanoparticles coated with macrophage-derived microvesicles for sustained, targeted delivery of dexamethasone to arthritic joints6
Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer’s disease5
Targeting WNT signalling pathways as new therapeutic strategies for osteoarthritis5
Mitochondrial-targeted liposome-based drug delivery – therapeutic potential and challenges5
Biomimetic Ca2+ nanogenerator based on ions interference strategy for tumour-specific therapy5
Emerging role of ferroptosis in diabetic retinopathy: a review5
Insight into modulators of sphingosine-1-phosphate receptor and implications for cardiovascular therapeutics5
Ghrelin inhibits myocardial pyroptosis in diabetic cardiomyopathy by regulating ERS and NLRP3 inflammasome crosstalk through the PI3K/AKT pathway5
Long-term residence and efficacy of adenovirus-mimetic nanoparticles in renal target tissue5
Novel polysaccharide building hybrid nanoparticles: remodelling TAMs to target ERα-positive breast cancer5
Light mediated drug delivery systems: a review5
Development of mRNA nano-vaccines for COVID-19 prevention and its biochemical interactions with various disease conditions and age groups5
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases5
Humanized recombinant immunotoxin targeting hCG demonstrates therapeutic potential for advanced stage difficult to treat cancers5
Targeting PRAS40: a novel therapeutic strategy for human diseases5
Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix5
Effect of Malt-PEG-Abz@RSL3 micelles on HepG2 cells based on NADPH depletion and GPX4 inhibition in ferroptosis5
Application of nanotechnology in management and treatment of diabetic wounds4
Protective effects of BP-1-102 against intracranial aneurysms-induced impairments in mice4
Aptamers: ushering in new hopes in targeted glioblastoma therapy4
Recent advances in PAMAM mediated nano-vehicles for targeted drug delivery in cancer therapy4
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes4
miR-1/133a and miR-206/133b clusters overcome HGF induced gefitinib resistance in non-small cell lung cancers with EGFR sensitive mutations4
Drug screening approaches for small-molecule compounds in cancer-targeted therapy4
Local delivery of ibrutinib by folate receptor-mediated targeting PLGA–PEG nanoparticles to glioblastoma multiform: in vitro and in vivo s4
Micro and nanorobot-based drug delivery: an overview4
Folic acid modified precision nanocarriers: charting new frontiers in breast cancer management beyond conventional therapies4
3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial status4
Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics4
Recent advances in nanoscale targeted therapy of HER2-positive breast cancer4
Integrating machine learning and multitargeted drug design to combat antimicrobial resistance: a systematic review4
Exploring the efficient natural products for Alzheimer’s disease therapy via Drosophila melanogaster (fruit fly) models4
The role of peptide-based therapeutics in oncotherapy4
Advancements in colorectal cancer immunotherapy: from CAR-T cells to exosome-based therapies4
Artificial intelligence in nanotechnology for treatment of diseases4
Molecular and therapeutic insight into ER stress signalling in NSCLC3
Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis3
Correction3
Elements in trace amount with a significant role in human physiology: a tumor pathophysiological and diagnostic aspects3
Absorption enhancer approach for protein delivery by various routes of administration: a rapid review3
The role of miRNAs and lncRNAs in conferring resistance to doxorubicin3
Therapeutic effects of the gold nanoparticle on obesity-triggered neuroinflammation: a review3
Sirtuins as therapeutic targets for improving delayed wound healing in diabetes3
Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide3
Clinical evaluation of liposome-based gel formulation containing glycolic acid for the treatment of photodamaged skin3
A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy3
Signalling in pancreatic cancer: from pathways to therapy3
Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer3
New generation of viral nanoparticles for targeted drug delivery in cancer therapy3
Recent advancement on albumin nanoparticles in treating lung carcinoma3
Hyaluronic acid prodrug micelles for tumour therapy3
Silver nanoparticle-based drug delivery systems in the fight against COVID-19: enhancing efficacy, reducing toxicity and improving drug bioavailability3
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitu3
An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives2
TGFβ1/integrin β3 positive feedback loop contributes to acquired EGFR TKI resistance in EGFR-mutant lung cancer2
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice2
siRNA knockdown of angiopoietin 2 significantly reduces neovascularization in diabetic rats2
Nanocarrier-based co-delivery approaches of chemotherapeutics with natural P-glycoprotein inhibitors in the improvement of multidrug resistance cancer therapy2
Recent advancements in nanomedicine based lipid metabolism for tumour immunotherapy2
Ferroptosis-targeting drugs in breast cancer2
Preparation and anti-inflammatory effect of mercury sulphide nanoparticle-loaded hydrogels2
Neurological manifestations of SARS-CoV-2 infections: towards quantum dots based management approaches2
Exploiting drug delivery systems for oral route in the peptic ulcer disease treatment2
Dual-targeted colon-based integrated micelle drug delivery system for treatment of ulcerative colitis2
Therapeutic and diagnostic applications of carbon nanotubes in cancer: recent advances and challenges2
HSP60 in cancer: a promising biomarker for diagnosis and a potentially useful target for treatment2
Chemical modification of curcumin increases its potency against hypopharyngeal carcinoma2
Macrophage targeted triptolide micelles capable of cGAS-STING pathway inhibition for rheumatoid arthritis treatment2
The anti-cancer properties of miR-340 plasmid-chitosan complexes (miR-340 CC) on murine model of breast cancer*2
Interactions and communications in lung tumour microenvironment: chemo/radiotherapy resistance mechanisms and therapeutic targets2
Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals2
Legumain protease-sheddable PEGylated, tuftsin-modified nanoparticles for selective targeting to tumour-associated macrophages2
Albumin-encapsulated HSP90-PROTAC BP3 nanoparticles not only retain protein degradation ability but also enhance the antitumour activity of BP3 in vivo2
The battle of lipid-based nanocarriers against blood-brain barrier: a critical review2
Improving selective targeting to cancer-associated fibroblasts by modifying liposomes with arginine based materials2
Active-site molecular docking of nigellidine with nucleocapsid–NSP2–MPro of COVID-19 and to human IL1R–IL6R and strong antioxidant role of Nigella sativa in experimental rats2
A pH-Driven indomethacin-loaded nanomedicine for effective rheumatoid arthritis therapy by combining with photothermal therapy2
Advanced polymers and recent advancements on gastroretentive drug delivery system; a comprehensive review2
A ROS-response hyaluronic acid-coated/chitosan polymer prodrug for enhanced tumour targeting efficacy of SN382
Novel studies on Drosophila melanogaster model reveal the roles of JNK-Jak/STAT axis and intestinal microbiota in insulin resistance2
Enhanced pharmacokinetic approach for anastrozole via macromolecule-based silk fibroin nanoparticles incorporated in situ injectables for oestrogen-positive breast cance2
A comprehensive review on recent advancements in drug delivery via selenium nanoparticles2
Pharmacological modulation of P2X4 in inflammatory bowel diseases: the way towards novel therapeutics?2
2,2,6,6-tetramethylpiperidin-1-oxyl: a new potential targeted ligand based on lipid peroxidation for targeted drug delivery2
Tumour microenvironment-responsive nanoplatform based on biodegradable liposome-coated hollow MnO2 for synergistically enhanced chemotherapy and photodynamic therapy2
Methodological Advances in Liposomal Encapsulation Efficiency Determination: Systematic Review and Analysis2
Advances in herbal polysaccharides-based nano-drug delivery systems for cancer immunotherapy2
0.1374990940094